Phase 1 Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man or woman between 18 and 75 years old
- Your body mass index (a measure of body weight relative to height) is between 17.5 and 40.0, and you weigh more than 50 kg (110 lbs)
- If you are a woman who could become pregnant, you and any male partner who has not had a vasectomy must agree to use highly effective birth control during the trial
If you have normal kidney function, you must also:
- Be in good general health with no significant issues found during medical history review, vital signs, blood tests, or heart tracing (ECG)
- Match certain characteristics (such as age, weight, and where possible, sex) to other participants in the study
- Have normal kidney function, with no known or suspected kidney problems (confirm with trial site for specific test values)
If you have reduced kidney function, you must also:
- Have a kidney function test result that confirms a certain level of kidney impairment, taken within 28 days before receiving the study drug
- Have any form of kidney impairment, except for a current active condition called acute nephritic syndrome (a past history of this condition that is now in remission may still be acceptable)
- Have been on stable medications to manage your health conditions for at least 28 days before your screening visit
- Have a heart tracing (ECG) and vital signs that meet the study's requirements
Who may not be able to join:
- You have a current or past illness that the study doctor believes could affect the results or put you at additional risk
- You have a history of heart rhythm problems, certain risk factors for a specific heart condition called Torsade de Pointes (such as low potassium levels or a family history of long QT syndrome), or significant/unstable heart disease (confirm with trial site)
- You have a history of a serious allergic reaction to a medication
- You have used recreational drugs or have a history of drug misuse within the past year
- You regularly drink more than 14 units of alcohol per week (if you are a woman) or more than 21 units per week (if you are a man)
- You are unwilling to avoid alcohol for 48 hours before the study starts through to the end of the follow-up period
- You have Hepatitis A, B, C, or E, HIV, or a current active infection such as COVID-19
- Your liver enzyme levels (specific blood test results) are more than twice the normal upper limit (confirm with trial site)
- Your bilirubin levels (a substance measured in blood) are more than 1.5 times the normal upper limit, unless a harmless condition called Gilbert's syndrome is suspected
- You are pregnant or have a positive pregnancy test at enrolment
If you have normal kidney function, you may also not be able to join if:
- Your haemoglobin (a measure of red blood cells) is below 10 g/dL
If you have reduced kidney function, you may also not be able to join if:
- You are currently receiving haemodialysis or peritoneal dialysis (kidney filtering treatments)
- Your haemoglobin is below 9 g/dL
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (800) 466-6059
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Area under the concentration time curve [AUC]; Maximum plasma concentration [Cmax]; Minimum plasma concentration [Cmin]; C0 [predose]; Half-life [t1/2]; Time to maximum plasma concentration [Tmax]; Apparent Clearance (CL/F); Apparent Volume of Distribution (V/F); Total Amount of Drug Excreted in Urine (Ae); Renal Clearance (CLr)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.